Pancreatic Cancer Research

ResearcherSamsung Medical CenterActive in the last 2 years

So Jeong Yoon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5227-4490; OpenAlex author ID A5084391508. Sources: OpenAlex.

Their work

Papers
16
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2021: 2 papers · 2022: 2 papers · 2023: 4 papers · 2024: none · 2025: 7 papers · 2026: 1 paper

Papers 16

  1. Development of an artificial intelligence-based prediction platform for early recurrence of resectable pancreatic cancer after curative surgery-toward future u… Co-author DOI 10.4174/astr.2026.110.2.76↗
  2. Artificial Intelligence-Powered Spatial Analysis of Immune Phenotypes in Resected Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2025.1999↗
  3. Synthetic data generation method improves risk prediction model for early tumor recurrence after surgery in patients with pancreatic cancer. Co-author DOI 10.1038/s41598-025-15800-4↗
  4. Implications of portal vein/superior mesenteric vein involvement in pancreatic cancer: A comprehensive correlation from preoperative radiological assessment to… Co-author DOI 10.1097/js9.0000000000002307↗
  5. Prognostic Accuracy of ypTNM Stage in Patients with Pancreatic Cancer in the Era of Modern Neoadjuvant Therapy. Co-author DOI 10.1245/s10434-024-16792-7↗
  6. Optimal Number of Lymph Nodes Retrieved to Lower the Risk of False N0 for Patients with Pancreatic Cancer Undergoing Curative Surgery. Co-author DOI 10.1245/s10434-025-18029-7↗
  7. Impact of portal/superior mesenteric vein abutment angle on prognosis in pancreatic cancer: a single-center retrospective cohort study. Co-author DOI 10.4174/astr.2025.108.4.231↗
  8. Predicting prognosis and optimal timing for surgery using CA 19-9 in patients with pancreatic cancer who underwent FOLFIRINOX-based neoadjuvant therapy: a retr… Co-author DOI 10.4174/astr.2025.109.6.348↗
  9. Use of individualized 3D-printed models of pancreatic cancer to improve surgeons' anatomic understanding and surgical planning. Co-author DOI 10.1007/s00330-023-09756-0↗
  10. Prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis. Co-author DOI 10.1111/ans.18679↗
  11. Survival Benefit after Shifting from Upfront Surgery to Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer. Co-author DOI 10.3390/biomedicines11082302↗
  12. 15-Year Experience of Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer-A Korean Nationwide Investigation. Co-author DOI 10.3390/cancers15153850↗
  13. Development of Nomograms for Predicting Prognosis of Pancreatic Cancer after Pancreatectomy: A Multicenter Study. Co-author DOI 10.3390/biomedicines10061341↗
  14. Pathological Response Predicts Survival after Pancreatectomy following Neoadjuvant FOLFIRINOX for Pancreatic Cancer. Co-author DOI 10.3390/cancers15010294↗
  15. Appraisal of 5-year recurrence-free survival after surgery in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jhbp.815↗
  16. Upfront Surgery and Surgery Following Neoadjuvant Treatment of Pancreatic Ductal Adenocarcinoma: A Comparative Analysis of Short-term Postoperative Outcomes. Co-author DOI 10.21873/anticanres.15386↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin Seok Heo · 16 shared papers, 2021–2026 · strength 3.35
  2. In Woong Han · 16 shared papers, 2021–2026 · strength 3.35
  3. Sang Hyun Shin · 15 shared papers, 2021–2026 · strength 3.16
  4. Hongbeom Kim · 11 shared papers, 2022–2026 · strength 2.53
  5. Hye Jeong Jeong · 7 shared papers, 2022–2025 · strength 1.54
  6. Hochang Chae · 5 shared papers, 2025 · strength 1.27
  7. Hyeong Seok Kim · 5 shared papers, 2025 · strength 1.27
  8. Ji Hye Min · 3 shared papers, 2023–2025 · strength 0.65
  9. Hyun Jeong Jeon · 3 shared papers, 2022–2023 · strength 0.55
  10. Sung Hyun Kim · 2 shared papers, 2025–2026 · strength 0.53
  11. Seung Soo Hong · 2 shared papers, 2025–2026 · strength 0.53
  12. Ho Kyoung Hwang · 2 shared papers, 2025–2026 · strength 0.53
  13. Chang Moo Kang · 2 shared papers, 2025–2026 · strength 0.53
  14. Ji Hye Jung · 2 shared papers, 2021 · strength 0.30
  15. Seung Hyup Hyun · 1 shared paper, 2025 · strength 0.24
  16. Yoo‐Seok Yoon · 1 shared paper, 2023 · strength 0.18
  17. Dae Wook Hwang · 1 shared paper, 2023 · strength 0.18
  18. Tae Ho Hong · 1 shared paper, 2023 · strength 0.18
  19. Jin‐Young Jang · 1 shared paper, 2023 · strength 0.18
  20. Sang‐Jae Park · 1 shared paper, 2023 · strength 0.18
  21. Kee‐Taek Jang · 1 shared paper, 2025 · strength 0.18
  22. Kyunga Kim · 1 shared paper, 2025 · strength 0.18
  23. Jong Kyun Lee · 1 shared paper, 2025 · strength 0.18
  24. Young Hoon Choi · 1 shared paper, 2025 · strength 0.18
  25. Hye Min Kim · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.